$25M Set Aside For Common Benefit Fees In Fresenius MDL

(November 6, 2017, 2:27 PM EST) -- BOSTON — The Massachusetts federal judge overseeing the Fresenius GranuFlo/NaturaLyte dialysate multidistrict litigation on Nov. 2 ordered that $27 million of the $250 million global settlement be set aside for plaintiffs’ counsel common benefit fees and expenses (In Re:  Fresenius GranuFlo/NaturaLyte Dialysate Products Liability Litigation, MDL Docket No. 2428, D. Mass.)....

Attached Documents

Related Sections